Therapy Patent Infringement Case: Gilead Sciences Wins Reversal of $1.2 Billion Awards with Bristol Myers
Gilead Sciences Inc. persuaded a U.S. appeals court to reverse a $1.2 billion judgment Bristol-Myers Inc. had won over revolutionary treatments that…